Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | PLA2G2C | Q5R387 | 3/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL820028 | 0.97 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL375645 | 0.97 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL8746528 | 0.92 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL9400013 | 0.92 | HSPD1 (0.38) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL17995738 | 0.89 | HSPD1 (0.40) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL17995590 | 0.87 | HSPD1 (0.38) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL6663512 | 0.86 | HSPD1 (0.37) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL7091309 | 0.82 | HSPD1 (0.33) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL16319164 | 0.82 | HSPD1 (0.44) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL4728898 | 0.81 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2613754-B1 | CURABLE COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2018-10-17 | — | — | EP | disclosed |
| US-9216141-B2 | Curable composition, process of production and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-12-22 | — | — | US | disclosed |
| EP-2582765-B1 | 2-ETHYLHEXYL METHYL TEREPHTHALATE AS PLASTICISERS IN ADHESIVES OR SEALANTS | BASF SE (DE) | 2014-10-15 | — | — | EP | disclosed |
| EP-2040857-B1 | LIQUID DISPENSER FOR MEDICAL PURPOSES IN THE FORM OF AN APPLICATOR | AESCULAP AG (DE) | 2014-07-02 | — | — | EP | disclosed |
| EP-2613754-A1 | CURABLE COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M Innovative Properties Company (US) | 2013-07-17 | — | — | EP | disclosed |
| US-20130157226-A1 | CURABLE COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-06-20 | — | — | US | disclosed |
| EP-2588246-A1 | PROCESS FOR PREPARING A THIXOTROPING AGENT AND USE THEREOF | Construction Research & Technology GmbH (DE) | 2013-05-08 | — | — | EP | disclosed |
| EP-2582765-A1 | 2-ETHYLHEXYL METHYL TEREPHTHALATE AS PLASTICISERS IN ADHESIVES OR SEALANTS | BASF SE (DE) | 2013-04-24 | — | — | EP | disclosed |
| WO-2012033633-A1 | CURABLE COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-15 | — | — | WO | disclosed |
| EP-2428199-A1 | Curable composition, process of production and use thereof | 3M Innovative Properties Company (US) | 2012-03-14 | — | — | EP | disclosed |
| WO-2012000774-A1 | PROCESS FOR PREPARING A THIXOTROPING AGENT AND USE THEREOF | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2012-01-05 | — | — | WO | disclosed |
| WO-2011161037-A1 | 2-ETHYLHEXYL METHYL TEREPHTHALATE AS PLASTICISERS IN ADHESIVES OR SEALANTS | BASF SE (DE) | 2011-12-29 | — | — | WO | disclosed |
| EP-2040857-A1 | LIQUID DISPENSER FOR MEDICAL PURPOSES IN THE FORM OF AN APPLICATOR AND USE OF THE SAME | Aesculap AG (DE) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008009386-A1 | LIQUID DISPENSER FOR MEDICAL PURPOSES IN THE FORM OF AN APPLICATOR AND USE OF THE SAME | AESCULAP AG (DE) | 2008-01-24 | — | — | WO | disclosed |
| US-6726671-B2 | Cell storage maintenance and monitoring system | GAMBRO, INC. | 2004-04-27 | — | — | US | disclosed |
| US-20020040216-A1 | Cell storage maintenance and monitoring system | GAMBRO, INC. | 2002-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130157226-A1 | CURABLE COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | LDHA, LDHB, SOD1 | HSPD1 2398/4885BLM 250/4885HSPE1 3438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.